IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Euclidean Capital LLC

Q4 2020 Holdings

Filed 2021-02-12 | 10 holdings | $15.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alector Inc(ALEC)COM014442107$14.8M980,89497.0%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$257.1K4,179,4161.7%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$63.1K2,083,6020.4%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$47.4K1,400,4350.3%
Denali Therapeutics Inc(DNLI)COM24823R105$27.1K323,7490.2%
Foghorn Therapeutics Inc(FHTX)COM344174107$25.6K1,261,2610.2%
Constellation Pharmceticls I(CNST)COM210373106$16.0K554,3250.1%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$14.5K735,8010.1%
Revolution Medicines Inc(RVMD)COM76155X100$3.7K93,4360.0%
First Finl Bancorp OH(FFBC)COM320209109$3.0K173,5760.0%